Ordenar per
Keyphrases
2-cycles
14%
Androgen Suppression
14%
B Cells
28%
Castration
14%
CD-8
14%
CD4+ T Cells
28%
CD8+ T Cells
28%
Circulating Immune Cells
14%
Circulating Leukocytes
14%
Common Cancers
14%
Flow Cytometry
14%
Healthy Donors
14%
Immunophenotyping
100%
Leukocyte Subsets
14%
Leukocytes
14%
Metastatic Castration-resistant Prostate Cancer (mCRPC)
100%
Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
14%
Monocytes
14%
Natural Killer Cells
14%
Neutrophils
14%
Non-invasive Biomarkers
14%
OX40
14%
Peripheral Blood
100%
Platelets
28%
Programmed Death-ligand 1 (PD-L1)
71%
Prostate Cancer
14%
Prostate Cancer Patients
14%
Radium-223
100%
Rapid Progression
14%
Slow Progression
28%
Medicine and Dentistry
Androgen Suppression
20%
B Cell
40%
CD8 Antigen
20%
Cytotoxic T-Cell
40%
Flow Cytometry
20%
Immunocompetent Cell
20%
Immunophenotyping
100%
Leukocyte
60%
Malignant Neoplasm
20%
Natural Killer Cell
20%
Neutrophil
20%
Platelet
40%
Programmed Death-Ligand 1
100%
Prospective Study
20%
Prostate Cancer
40%
T-Helper Cell
40%
Biochemistry, Genetics and Molecular Biology
B Cell
40%
CD4
40%
CD8
60%
Flow Cytometry
20%
Immunocompetent Cell
20%
Immunophenotyping
100%
Leukocyte
60%
Natural Killer Cell
20%
PD-L1
100%
Platelet
40%
Prospective Study
20%
T Cell
80%
Neuroscience
Androgen
14%
B Cell
28%
CD4
28%
CD8
42%
Flow Cytometry
14%
Immunophenotyping
100%
Leukocyte
42%
Natural Killer Cell
14%
Platelet
28%
Radium-223
100%
T Cell
57%
Immunology and Microbiology
B Cell
40%
CD8
20%
Cytotoxic T-Cell
40%
Immunocompetent Cell
20%
Leukocyte
60%
Natural Killer Cell
20%
Neutrophil
20%
Platelet
40%
Programmed Death-Ligand 1
100%
T-Helper Cell
40%
Pharmacology, Toxicology and Pharmaceutical Science
Androgen
33%
CD8 Antigen
100%
Flow Cytometry
33%
Malignant Neoplasm
33%
Prospective Study
33%
Prostate Cancer
66%